Differentiating Between Brain Hemorrhage and Contrast

NCT06032819 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2023-09-13

No results posted yet for this study

Summary

The goal of this observational study is to use artificial intelligence to differentiate cerebral hemorrhage from contrast agent extravasation after mechanical revascularization in ischemic stroke.

The main question it aims to answer is: Whether artificial intelligence can help differentiate brain hemorrhage from contrast agent extravasation.

Patients with intracranial high-density lesions on CT scans within 24h after mechanical revascularization will be included. Expected to enroll 500 patients. The type of high-density lesion is determined according to dual-energy CT images or follow-up images. Patients will be divided into training group, validation and testing groups by stratified random sampling (6:2:2). After the images and the image labels are obtained, deep learning artificial intelligence will be used to learn the image characteristics and establish a diagnostic model, and the model performance and generalization ability will be evaluated.

Conditions

Sponsors & Collaborators

  • Hong Kong University of Science and Technology

    collaborator OTHER
  • First Affiliated Hospital, Sun Yat-Sen University

    collaborator OTHER
  • The Seventh Affiliated Hospital of Sun Yat-sen University

    collaborator OTHER
  • Peking University Shenzhen Hospital

    collaborator OTHER
  • The Third Affiliated Hospital of Guangzhou Medical University

    collaborator OTHER
  • The Third Affiliated Hospital of Southern Medical University

    collaborator OTHER_GOV
  • Shenshan Medical Center, Memorial Hospital of Sun Yat-sen University

    collaborator UNKNOWN
  • Shantou Central Hospital

    collaborator OTHER
  • Dongguan People's Hospital

    collaborator OTHER_GOV
  • The First People's Hospital of Qinzhou

    collaborator UNKNOWN
  • Guangdong 999 Brain Hospital

    collaborator OTHER
  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-30
Primary Completion
2024-07-31
Completion
2024-12-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06032819 on ClinicalTrials.gov